Now in its 20th year, this hallmark conference for pharmaceutical and biotechnology executives will continue to provide cutting-edge presentations and candid panel discussions on breakthrough concepts and developments which are critical to cancer drug development and commercialization.

The rapid growth in the number of individuals alive with cancer is driving the demand for a new generation of cancer therapeutics that improve patient outcomes. Discussions from leaders in research and industry will cover emerging cancer targets, combination therapies, developments in translational research, adaptive trial design, new research directions in autophagy and metabolism and how these new agents are reshaping treatment strategies.

• The current 95% attrition rate for cancer drugs is unacceptable. A panel of seasoned drug developers will discuss what is being done to mitigate the risk of future drug failures.

• In an economy that is forcing downsizing and reduction of operating expenses, what new paradigms are changing the business models in oncology? An expert on this industry will discuss these important issues.

• Payers are demanding more evidence to support coverage and payment decisions, what are the global healthcare outcomes and health technology assessments that need to be incorporated into clinical programs in order to get drugs reimbursed? A panel of high-ranking experts will engage in a lively dialogue that will assess the landscape, and describe innovative solutions.

Our stellar faculty of presenters and panelists offers a mother-lode of information and insights. Attendees receive a conference handbook and web-access to slides, plus the annually-updated report on Oncology Drugs in the Pipeline.

The conference provides abundant opportunities for high-level networking during continental breakfasts, refreshment breaks and luncheons plus a gala cocktail reception.

Plan now to join us for strategic discussions, lively audience interactions and an unsurpassed learning experience.

Registration Form                  Last Year's Program (March, 2008)